Last €7.99 EUR
Change Today +0.124 / 1.58%
Volume 33.6K
ABLX On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
OTC US
As of 11:35 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edwin Moses Ph.D.

Chief Executive Officer and Director, Ablynx NV
AgeTotal Calculated CompensationThis person is connected to 38 board members in 6 different organizations across 9 different industries.

See Board Relationships
60--

Background*

Dr. Edwin Moses, Ph.D. serves as the Chief Executive Officer of Ablynx NV and served as its Chief Executive Officer since June 6, 2006. Dr. Moses served as a Consultant of Evotec AG (formerly Evotec Oai AG) since June 7, 2005. Dr. Moses has over twenty-five years experience in the life sciences and biotechnology sectors. He has worked for many leading companies in a senior capacity including Amersham International, Oxford Asymmetry International plc and Evotec OAI. Dr. ...

Read Full Background

Corporate Headquarters*

Technologiepark 21
Ghent, East Flanders 9052

Belgium

Phone: 32 9 262 00 00
Fax: 32 9 262 00 01

Board Members Memberships*

Non-Executive Chairman, Chairman of Audit Committee, Chairman of Nominations Committee and Member of Remuneration Committee
Chairman
Non-Executive Chairman
Former Executive Chairman
Non-Executive Chairman
Former Non-Executive Director
Chief Executive Officer and Director
Executive Chairman
2004-Present
Non-Executive Chairman, Chairman of Nomination Committee, Chairman of Remuneration Committee and Member of Audit Committee
2004-2009
Former Non-Executive Director, Member of Audit Committee and Member of Remuneration Committee

Education*

Doctorate 1979
The University of Sheffield

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABLX:BB €7.99 EUR +0.124

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Daniel M. Junius Chief Executive Officer, President and Director
ImmunoGen, Inc.
$544.5K
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
€546.0K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
John Dawson Chief Executive Officer and Director
Oxford BioMedica PLC
429.0K GBP
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABLYNX NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.